FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

RNAi related Press Releases

Alnylam Pharmaceuticals Earns $20 Million Payment from Takeda Pharmaceutical Co. Ltd.

Posted October 7, 2008

Alnylam Pharmaceuticals Earns $20 Million Payment from Takeda Pharmaceutical Co. Ltd. October 7, 2008 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading... Read more...

PRESS RELEASE: Amarin Corporation to Buy Privately Held Ester Neurosciences for up to $17M

Posted December 5, 2007

Amarin Corporation to Buy Privately Held Ester Neurosciences for up to $17M LONDON, December 5 -- Amarin Corporation today announced that the Company has: - Signed an agreement to acquire Ester... Read more...

PRESS RELEASE: Nastech Pharmaceutical Company to Establish Subsidiary, MDRNA

Posted November 14, 2007

Nastech Pharmaceutical Company to Establish Subsidiary, MDRNA, as an Independent Company to Focus on the Development of RNA-Based Therapeutics BOTHELL, Wash., Nov. 13 -- Nastech Pharmaceutical... Read more...

PRESS RELEASE: Merck Licenses SNALP Technology from Protiva

Posted October 17, 2007

MERCK LICENSES SNALP TECHNOLOGY FROM PROTIVA Protiva to Receive One-Time Payment with Potential Milestone and Royalty Payments as Part of Broader Agreement VANCOUVER, BRITISH COLUMBIA--(October 16,... Read more...